| Literature DB >> 26593299 |
Vandana Khungar1, David Seth Goldberg2.
Abstract
Liver transplantation (LT) is an established lifesaving therapy for patients with cholestatic liver diseases, including primary cholestatic diseases, namely primary sclerosing cholangitis and primary biliary cirrhosis, as well as secondary forms of cholestatic liver disease, including those with cholestatic complications of LT needing a retransplant. Patients with cholestatic liver diseases can be transplanted for complications of end-stage liver disease or for disease-specific symptoms before the onset of end-stage liver disease. These patients should be regularly assessed. Patient survival after LT for cholestatic liver diseases is generally better than for other indications.Entities:
Keywords: Cholestatic liver disease; Living donor transplantation; MELD exceptions; Waitlist mortality
Mesh:
Year: 2015 PMID: 26593299 PMCID: PMC4660247 DOI: 10.1016/j.cld.2015.08.011
Source DB: PubMed Journal: Clin Liver Dis ISSN: 1089-3261 Impact factor: 6.126